PREPROPOSAL STATEMENT OF INQUIRY
(Board of Pharmacy)
Subject of Possible Rule Making: WAC 246-889-050 Suspicious transactions, this rule regulates the sale and/or transfer of ephedrine, pseduoephedrine [pseudoephedrine], and phenylpropanolamine products.
Statutes Authorizing the Agency to Adopt Rules on this Subject: RCW 69.43.035 and 18.64.005(7).
Reasons Why Rules on this Subject may be Needed and What They Might Accomplish: Recent legislation, ESSB 6478, changed the reporting thresholds for suspicious transactions. Existing rules need to be updated to reflect current thresholds. The board will also consider developing a standard format for the reporting of suspicious transactions.
Other Federal and State Agencies that Regulate this Subject and the Process Coordinating the Rule with These Agencies: Drug Enforcement Administration (DEA) also regulates these substances. The Department of Health will coordinate with the DEA during the stakeholder process.
Process for Developing New Rule: Collaborative rule making.
Interested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Lisa Salmi, Department of Health, Board of Pharmacy, P.O. Box 47863, Olympia, WA 98504-7863, Lisa.Salmi@doh.wa.gov, phone (360) 236-4828, or fax (360) 586-4359.
August 5, 2004